Literature DB >> 6814734

Bolus intravenous nitroglycerin for ST-segment depression not associated with increased myocardial oxygen demand.

E A Kopman, A F del Real.   

Abstract

Ischaemic ST-segment changes may occur in patients with coronary artery disease when myocardial oxygen consumption is increased as a result of hypertension, tachycardia or increased contractility. Ischaemia can also occur as the result of decreased coronary perfusion pressure caused by hypotension or coronary artery spasm. We report ST-segment depression in the absence of hypertension, tachycardia or hypotension. The response to bolus intravenous nitroglycerin suggested coronary artery spasm as the cause.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6814734     DOI: 10.1007/bf03007738

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  24 in total

Review 1.  Coronary-artery spasm.

Authors:  L D Hillis; E Braunwald
Journal:  N Engl J Med       Date:  1978-09-28       Impact factor: 91.245

2.  Ergonovine maleate provocative test for coronary arterial spasm.

Authors:  F A Heupler; W L Proudfit; M Razavi; E K Shirey; R Greenstreet; W C Sheldon
Journal:  Am J Cardiol       Date:  1978-04       Impact factor: 2.778

3.  "Variant" angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients.

Authors:  A Maseri; S Severi; M D Nes; A L'Abbate; S Chierchia; M Marzilli; A M Ballestra; O Parodi; A Biagini; A Distante
Journal:  Am J Cardiol       Date:  1978-12       Impact factor: 2.778

4.  Clinical and arteriographic features of Prinzmetal's variant angina: documentation of etiologic factors.

Authors:  C B Higgins; L Wexler; J F Silverman; J S Schroeder
Journal:  Am J Cardiol       Date:  1976-05       Impact factor: 2.778

5.  Altered adrenergic activity in coronary arterial spasm: insight into mechanism based on study of coronary hemodynamics and the electrocardiogram.

Authors:  D R Ricci; A E Orlick; P R Cipriano; D F Guthaner; D C Harrison
Journal:  Am J Cardiol       Date:  1979-06       Impact factor: 2.778

6.  Nifedipine therapy for coronary-artery spasm. Experience in 127 patients.

Authors:  E Antman; J Muller; S Goldberg; R MacAlpin; M Rubenfire; B Tabatznik; C S Liang; F Heupler; S Achuff; N Reichek; E Geltman; N Z Kerin; R K Neff; E Braunwald
Journal:  N Engl J Med       Date:  1980-06-05       Impact factor: 91.245

7.  Spectrum of coronary arterial spasm. Clinical, angiographic and myocardial metabolic experience in 29 cases.

Authors:  L Wiener; H Kasparian; P R Duca; P Walinsky; R S Gottlieb; F Hanckel; A N Brest
Journal:  Am J Cardiol       Date:  1976-12       Impact factor: 2.778

8.  Nifedipine therapy for Prinzmetal's angina.

Authors:  J E Muller; S J Gunther
Journal:  Circulation       Date:  1978-01       Impact factor: 29.690

9.  A controlled trial of verapamil for Prinzmetal's variant angina.

Authors:  S M Johnson; D R Mauritson; J T Willerson; L D Hillis
Journal:  N Engl J Med       Date:  1981-04-09       Impact factor: 91.245

10.  Comparison of coronary arteriographic findings during angina pectoris associated with S-T elevation or depression.

Authors:  H Yasue; S Omote; A Takizawa; N Masao; H Hyon; S Nishida; M Horie
Journal:  Am J Cardiol       Date:  1981-03       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.